Immune response of covid-19 vaccines
Conditions
Interventions
Gold Standard:Pathological results or follow-up results.
Index test:SUVmax, 
and 
titer 
of 
SV-CoV-2, 
C-reaction 
protein,lymphocyte 
blood 
routine. 
Sponsors
Department of Nuclear Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Patients sign informed consent voluntarily; 2.Aged > 18 years with COVID-19 vaccine adaptation; The nucleic acid test and antibody results for COVID-19 were negative before vaccination; 3.Patients be vaccinated with covid-19 vaccines recently; 4.Patients were in good health.
Exclusion criteria
Exclusion criteria: 1.Pregnant women; 2.Subjects with history of vaccine allergy and other vaccination history within one year; 3.Oral administration or parenteral injection of steroids or immunosuppressive / immunomodulatory drugs within 3 months before and after PET scanning; 4.Radiotherapy history within 3 months before and after PET scanning; 5.Other situations that may interfere with the research results during the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SUV maximum;Specific neutralizing antibody and titer of SV-CoV-2; | — |
Secondary
| Measure | Time frame |
|---|---|
| C-reaction protein;Lymphocyte immune function complete set;Blood routine; | — |
Countries
China
Contacts
Public ContactZhu Xiaohua
Department of Nuclear Medicine, Tongji Hospital
Outcome results
None listed